hrp0095p1-89 | Fetal, Neonatal Endocrinology and Metabolism | ESPE2022

A standard operating procedure for prevention, diagnosis, and management of hypoglycaemia in neonates ≥ 35 weeks of gestation

Roeper Marcia , Hoermann Henrike , Koestner Felix , Salimi Dafsari Roschan , Mayatepek Ertan , Kummer Sebastian , Meissner Thomas

Background: Hypoglycaemia is a common metabolic condition affecting up to 15% of all neonates and 50% of neonates with risk factors including diabetic mothers, large or small for gestational age, perinatal stress, or prematurity. It is well known that severe and prolonged hypoglycaemia, as commonly seen in congenital hyperinsulinism, can lead to brain injury. However, data on the effect of mild neonatal hypoglycaemia on neurodevelopment are limited. There is s...

hrp0092p2-144 | Fetal, Neonatal Endocrinology and Metabolism (to include Hypoglycaemia) | ESPE2019

Glucagon Therapy In Preterm Infants With Hyperinsulinemic Hypoglycaemia

Salimi Dafsari Roschan , Roper Marcia , Groß Maximilian , Wiechers Cornelia , Sabir Hemmen , Mayatepek Ertan , Meissner Thomas

Background: The treatment of preterms with hyperinsulinemic hypoglycaemia is a well-known challenge. One of the difficulties of the therapy is the excessive application of intravenous fluids to compensate high carbohydrate needs. There are various drug alternatives such as glucagon, diazoxide or somatostatin analogues apart from intravenous glucose application.Hypothesis: Intravenous or continuous subcutaneous glucagon t...